Project Number GC-2013561 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2017 View Full Project Details for Phase II Study to Assess Safety and Target Engagement in AMYX0035 in AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator Leslie, Kent Principal Investigator First Name Kent Principal Investigator Last Name Leslie Awardee Organization Amylyx Pharmaceuticals, Inc. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $928,234 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
